Latest News Archive
Please select Category, Year, and then Month to display items
23 November 2022
|
Story André Damons
![]()
Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.
The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.
The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS.
Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
GMO Testing Facility receives visit from Norwegian Embassy and other government departments
2009-04-23
 |
The GMO Testing Facility in the Department of Haematology and Cell Biology of the University of the Free State (UFS) recently received a visit from representatives of the Royal Norwegian Embassy, the Department of Environmental Affairs and Tourism (DEAT) and the National Biodiversity Institute (SANBI). The GMO Testing Facility provides diagnostic detection and quantification of genetically modified organisms (GMOs) in grain and processed foods for the food industry in South Africa. Prof. Chris Viljoen who is the Director of the facility, recently received a grant of R3,284 million for research on the biosafety of GMOs in South Africa. The grant forms part of a collaboration agreement between South Africa and Norway. The delegation paid a courtesy visit to the facility to discuss the project as well as visit ongoing field trials. Here are, from the left, front: Mr Shoni Munzhedzi, Chief Director for Biodiversity Management at the DEAT, Ms Theressa Frantz, Director for Applied Biodiversity Research at SANBI, Prof. Letticia Moja, Dean of the Faculty of Health Sciences at the UFS, and Prof. Chris Viljoen from the university’s GMO Testing Facility; back: Mr Tim Lund, Counsellor to the Royal Norwegian Embassy, and Prof. Teuns Verschoor, Acting Rector of the UFS.
Photo: Stephen Collett |